5.09266
Mcl-1 Inhibitor III, UMI-77
别名:
Mcl-1 Inhibitor III, UMI-77, Myeloid Cell Leukemia-1 Inhibitor III, UMI77, 2-(4-(4-Bromophenylsulfonamido)-1-hydroxynaphthalen-2-ylthio)acetic acid, ((4-(((4-Bromophenyl)sulfonyl)amino)-1-hydroxy-2-naphthyl)sulfanyl)acetic acid
方案
≥98% (HPLC)
质量水平
表单
solid
制造商/商品名称
Calbiochem®
储存条件
OK to freeze
protect from light
颜色
off-white
溶解性
DMSO: 10 mg/mL
储存温度
2-8°C
一般描述
A cell-permeable hydroxynaphthalenylthioacetate that exhibits Mcl-1-selective affinity (Ki against 2 nM FITC-BID79-99 binding = 490 nM/90 nM MCl-1 & 23.83 µM/60 nM Bcl-2; Ki against 1 nM FAM-BID80-99 binding = 5.33 µM/4 nM A1/Bfl-1; Ki against 2 nM FAM-BID80-99 binding = 8.19 µM/40 nM Bcl-w, 23.83 µM/60 nM Bcl-2, and 32.99 µM/50 nM Bcl-xL), effectively inhibiting Mcl-1 BH3-binding groove-mediated interactions with various binding partners, including Noxa, Bax, and Bak, by simultaneously targeting the groove′s h2 & h3 hydrophobic pockets. Shown to inhibit the proliferation of BxPC-3, Panc-1, and Capan-2 prostate cancer cultures (IC50 = 3.4, 4.4, and 5.5 µM, respectively) via apoptosis induction, while being less potent toward MiaPaca and AsPC-1 lines (IC50 = 12.5 and 16.1 µM, respectively) with high Bcl-xL and low Mcl-1/Bak expression and. Despite its moderate in vitro murine liver microsome stability (t1/2 = 45 mins), daily i.v. injection (60 mg/kg; 5 d/wk) is reported to effectively suppress BxPC-3 tumor expansion in mice in vivo without apparent animal toxicity, although severe weight loss is observed among mice received higher daily MUI-77 i.v. dosage of 80 mg/kg.
A cell-permeable, bioavailable hydroxynaphthalenylthioacetate compound that selectively and reversibly binds to the BH3 binding groove of Mcl-1 (Ki = 490 nM) and antagonizes its function by disrupting the heterodimerization of Mcl-1/Bax (IC50 = 1.43 µM) and Mcl-1/Bak in cells. Exhibits high selectivity over other members of the Bcl-2 family (Ki = 5.33, 8.19, 23.83, and 32.99 µM, for A1/Bfl-1, Bcl-w, Bcl-2, and Bcl-xL, respectively). Inhibits the growth of BxPC-3, Panc-1 cells, and Capan-2 cells (IC50 = 3.4, 4.4, and 5.5 µM, respectively) by inducing intrinsic apoptosis as evidenced by cytochrome c release and caspase-3 activation. However, it does not induce apoptosis in normal cells. Blocks the growth of BxPC-3 xenograft in SCID mice (60 mg/kg i.v. for 5 days for 2 weeks) without any cytotoxic effects on surrounding normal tissue. Exhibits desirable microsomal stability (t1/2 = 45 min. in murine models).
生化/生理作用
Cell permeable: yes
Primary Target
binds to the BH3 binding groove of Mcl-1
binds to the BH3 binding groove of Mcl-1
制备说明
Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
Use only fresh DMSO for reconstitution.
其他说明
Abulwerdi, F., et al. 2014. Mol. Cancer Ther.13, 565.
法律信息
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
免责声明
Toxicity: Standard Handling (A)
储存分类代码
11 - Combustible Solids
WGK
WGK 3
闪点(°F)
Not applicable
闪点(°C)
Not applicable
法规信息
新产品
此项目有
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持